Melanie B. Laederich

Author

Oregon Health & Science University

Also Known As

Laederich, Melanie B., M B Laederich, Melanie B Laederich, Melanie B. Laederich, Melanie Laederich

Publications

895

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Shriners Hospitals for Children - Portland UC Davis Comprehensive Cancer Center University of California Davis Medical Center

About

Melanie B. Laederich is an author at Oregon Health & Science University specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	696
2	Cell Biology	8	8	664
3	Molecular Biology	2	2	74
4	Natural Sciences	1	1	45
5	Cellular Physiology	1	1	41

Melanie B. Laederich

Publications

744

Citations

H-Index

Page 1

	Year	Citations
The Leucine-rich Repeat Protein LRIG1 Is a Negative Regulator of ErbB Family Receptor Tyrosine Kinases Melanie B. Laederich, Melanie Funes-Duran, Lily Yen, Journal of Biological Chemistry Developmental BiologySignal TransductionNegative RegulatorCell RegulationGrowth Factor	2004	237
LRIG1 Is a Novel Negative Regulator of the Met Receptor and Opposes Met and Her2 Synergy David L. Shattuck, Jamie K. Miller, Melanie B. Laederich, Molecular and Cellular Biology Invasive GrowthMet ReceptorCancer BiologyTumor BiologySignaling Pathway	2006	125
The Interaction of Piasy with Trim32, an E3-Ubiquitin Ligase Mutated in Limb-girdle Muscular Dystrophy Type 2H, Promotes Piasy Degradation and Regulates UVB-induced Keratinocyte Apoptosis through NFκB Amador Albor, Sally El-Hizawi, Elizabeth J. Horn, Journal of Biological Chemistry ApoptosisCell DeathPiasy UbiquitinationCytoskeletonSignaling Pathway	2006	83
LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII Monica A. Stutz, David L. Shattuck, Melanie B. Laederich, Oncogene Signal TransductionSignaling PathwayReceptor Tyrosine KinaseMedicineCell Biology	2008	80
Multimodular biosensors reveal a novel platform for activation of G proteins by growth factor receptors Krishna Midde, Nicolas Aznar, Melanie B. Laederich, Proceedings of the National Academy of Sciences	2015	48
Fibroblast Growth Factor Receptor 3 (FGFR3) Is a Strong Heat Shock Protein 90 (Hsp90) Client Melanie B. Laederich, Catherine Degnin, Gregory P. Lunstrum, Journal of Biological Chemistry FibrosisSignal TransductionStrong Hsp90 ClientProtein FunctionSignaling Pathway	2011	45
Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3 Catherine Degnin, Melanie B. Laederich, William A. Horton Molecular Biology of the Cell PathologyCell ProliferationCell GrowthCellular PhysiologyNuclear Localization	2011	41
Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: A severe form of human achondroplasia Changsheng Guo, Catherine Degnin, Melanie B. Laederich, Cellular Signalling Developmental BiologyHuman GrowthMedicineGenetic DisorderPathology	2008	32
The A391E mutation enhances FGFR3 activation in the absence of ligand Fenghao Chen, Catherine Degnin, Melanie B. Laederich, Biochimica et Biophysica Acta (BBA) - Biomembranes Signaling PathwayCell RegulationReceptor Tyrosine KinaseMolecular BiologyFibroblast Growth Factor	2011	29
FGFs in endochondral skeletal development Catherine Degnin, Melanie B. Laederich, William A. Horton Journal of Cellular Biochemistry MechanobiologyDevelopmental BiologyOrthopaedic SurgeryCognate Fgf ReceptorsBone Morphogenic Protein	2010	24

Page 1